Verapamil Tablets Recalled for Potential Labeling Mixup
Aidapak Services is recalling Verapamil HCL tablets because they may have been mislabeled as Atorvastatin or Tacrolimus.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (mislabeling) without reported injuries or illnesses, fitting the criteria for a moderate severity score.
Plain-English summary
Aidapak Services, LLC is recalling Verapamil HCL, 40 mg tablets (NDC 00591040401) due to a potential labeling mixup. The affected products may have been mislabeled as Atorvastatin Calcium, 10 mg tablets, or Tacrolimus, 1 mg capsules.
The recalled Verapamil tablets were repacked and distributed in Arizona, California, Oregon, and Washington. The specific lots involved have pedigree numbers W003170 (expiration 6/13/2014) and W003353 (expiration 6/18/2014).
Patients and healthcare providers should verify the labels on their medications. If the medication is identified as Verapamil HCL, 40 mg tablets with the affected pedigree numbers, it should be returned to the pharmacy or healthcare provider for replacement or disposal.
The recalled product
- Product
- VERAPAMIL HCL, Tablet, 40 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00591040401.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 196
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- VERAPAMIL HCL
- Tablet
- 40 mg has the following codes: Pedigree: W003170
- EXP: 6/13/2014
- Pedigree: W003353
- EXP: 6/18/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateVerapamil HCL ER Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Atorvastatin Calcium Tablets Due to Labeling Error
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Diphenhydramine Tablets Due to Potential Labeling Mixup
FDA (Drugs) · 2014-01-22
- SeverePramipexole Tablets Recalled for Potential Label Mixup with Tacrolimus
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Pancrelipase DR Capsules Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- ModerateDesipramine HCL Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-22